“Shot in the arm” for vaccine development

Israel’s Nasvax will receive a NIS 3.5 million grant to help finance development of its vaccines to prevent graft rejection after transplantation, and to treat Streptococcus pneumoniae, and Alzheimer’s disease.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000719389&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.